
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12624951
[patent_doc_number] => 20180100147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHODS AND COMPOSITIONS FOR GENERATING CRISPR GUIDE RNA LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 15/727279
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15727279
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/727279 | Methods and compositions for generating CRISPR guide RNA libraries | Oct 5, 2017 | Issued |
Array
(
[id] => 16484283
[patent_doc_number] => 20200377884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => CRISPR Fluorescent Guide RNA (fgRNA) to Understanding gRNAs Expressed from Pol II Promotors
[patent_app_type] => utility
[patent_app_number] => 16/632792
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632792 | CRISPR fluorescent guide RNA (fgRNA) to understanding gRNAs expressed from pol II promotors | Sep 28, 2017 | Issued |
Array
(
[id] => 16549960
[patent_doc_number] => 10883109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Methods of modulating mRNA stability and protein expression
[patent_app_type] => utility
[patent_app_number] => 15/713081
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 31
[patent_no_of_words] => 18813
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713081 | Methods of modulating mRNA stability and protein expression | Sep 21, 2017 | Issued |
Array
(
[id] => 16549960
[patent_doc_number] => 10883109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Methods of modulating mRNA stability and protein expression
[patent_app_type] => utility
[patent_app_number] => 15/713081
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 31
[patent_no_of_words] => 18813
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 298
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15713081
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/713081 | Methods of modulating mRNA stability and protein expression | Sep 21, 2017 | Issued |
Array
(
[id] => 12125142
[patent_doc_number] => 20180008728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection'
[patent_app_type] => utility
[patent_app_number] => 15/709908
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22746
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709908 | Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detection | Sep 19, 2017 | Abandoned |
Array
(
[id] => 12126569
[patent_doc_number] => 20180010152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'NOVEL DNA-BINDING PROTEINS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/709969
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 65939
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709969
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709969 | DNA-binding proteins and uses thereof | Sep 19, 2017 | Issued |
Array
(
[id] => 18545503
[patent_doc_number] => 11718844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Mirac proteins
[patent_app_type] => utility
[patent_app_number] => 15/699543
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27209
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699543
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699543 | Mirac proteins | Sep 7, 2017 | Issued |
Array
(
[id] => 13703243
[patent_doc_number] => 20170362576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => Host Cell Modification with Artificial Endosymbionts
[patent_app_type] => utility
[patent_app_number] => 15/694085
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/694085 | Host cell modification with artificial endosymbionts | Aug 31, 2017 | Issued |
Array
(
[id] => 13736565
[patent_doc_number] => 20180372750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/688635
[patent_app_country] => US
[patent_app_date] => 2017-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15688635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/688635 | ANTIBODY AND ANTIBODY MIMETIC FOR VISUALIZATION AND ABLATION OF ENDOGENOUS PROTEINS | Aug 27, 2017 | Abandoned |
Array
(
[id] => 17287220
[patent_doc_number] => 11203761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Genetically engineered Vibrio sp. and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/687373
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 24
[patent_no_of_words] => 19281
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687373
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687373 | Genetically engineered Vibrio sp. and uses thereof | Aug 24, 2017 | Issued |
Array
(
[id] => 16298020
[patent_doc_number] => 20200283743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/325892
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 196840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325892 | NOVEL CRISPR ENZYMES AND SYSTEMS | Aug 16, 2017 | Pending |
Array
(
[id] => 15619415
[patent_doc_number] => 20200080112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/325898
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 220750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/325898 | Crispr enzymes and systems | Aug 16, 2017 | Issued |
Array
(
[id] => 12092813
[patent_doc_number] => 20170349906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST'
[patent_app_type] => utility
[patent_app_number] => 15/678342
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14419
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678342
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/678342 | Expression constructs and methods of genetically engineering methylotrophic yeast | Aug 15, 2017 | Issued |
Array
(
[id] => 12980698
[patent_doc_number] => 20170342442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES
[patent_app_type] => utility
[patent_app_number] => 15/677435
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677435
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677435 | RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES | Aug 14, 2017 | Abandoned |
Array
(
[id] => 14291805
[patent_doc_number] => 10286010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Methods of treating neurodegenerative conditions
[patent_app_type] => utility
[patent_app_number] => 15/661281
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 17273
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15661281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/661281 | Methods of treating neurodegenerative conditions | Jul 26, 2017 | Issued |
Array
(
[id] => 15557505
[patent_doc_number] => 20200063164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 16/311265
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311265 | Genome editing | Jul 26, 2017 | Issued |
Array
(
[id] => 14407581
[patent_doc_number] => 20190169634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => GENETIC ERASERS
[patent_app_type] => utility
[patent_app_number] => 16/319786
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15599
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319786
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319786 | GENETIC ERASERS | Jul 25, 2017 | Abandoned |
Array
(
[id] => 12728776
[patent_doc_number] => 20180134759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/654419
[patent_app_country] => US
[patent_app_date] => 2017-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15654419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/654419 | METHODS FOR GENERATING ENDOGENOUSLY TAGGED PROTEINS | Jul 18, 2017 | Abandoned |
Array
(
[id] => 14535241
[patent_doc_number] => 20190203242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => SCALABLE BIOTECHNOLOGICAL PRODUCTION OF DNA SINGLE STRAND MOLECULES OF DEFINED SEQUENCE AND LENGTH
[patent_app_type] => utility
[patent_app_number] => 16/329495
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329495
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329495 | Scalable biotechnological production of DNA single strand molecules of defined sequence and length | Jul 16, 2017 | Issued |
Array
(
[id] => 15574595
[patent_doc_number] => 10577667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Systems and methods for microbial toxin detection
[patent_app_type] => utility
[patent_app_number] => 15/646177
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 9444
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15646177
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/646177 | Systems and methods for microbial toxin detection | Jul 10, 2017 | Issued |